Back to Search Start Over

Feasibility and safety of transfemoral transcatheter aortic valve implantation performed with a percutaneous coronary intervention-like approach

Authors :
Habib Sylla
Basile Verdier
Emmanuel Robin
Mohamad Koussa
Sina Porouchani
Julien Labreuche
Antoine Bical
G. Schurtz
Adeline Pierache
Thomas Modine
Flavien Vincent
Arnaud Sudre
Vincent Balmette
Nicolas Debry
Eric Van Belle
Jacques Desbordes
Nicolas Lamblin
Hugues Spillemaeker
Thibault Pamart
David Aouate
Gilles Lemesle
Benjamin Roy
Dany Janah
Alessandro Cosenza
Cedric Delhaye
Tom Denimal
Thomas Denis
Julien Ternacle
Mouhamed Moussa
Source :
Archives of cardiovascular diseases. 114(8-9)
Publication Year :
2020

Abstract

Summary Background Transfemoral percutaneous transcatheter aortic valve implantation (TF-TAVI) is a safe, reproducible and established procedure, mainly performed under local anaesthesia, which is mostly administered and monitored by a dedicated anaesthesia team (regular approach). Our centre has developed a standardized pathway of care, and eligible patients are selected for a minimalist TF-TAVI, entirely managed by operators without the presence of the anaesthesia team in the operating room, like most interventional coronary procedures (“percutaneous coronary intervention-like” approach [PCI approach]). Aim To compare the safety and efficacy of TF-TAVI performed with the PCI approach versus the regular approach. Methods The analysis population comprised all patients who underwent TF-TAVI with the PCI or regular approach in our institution from November 2016 to July 2019. The two co-primary endpoints were early safety composite and early efficacy composite at 30 days as defined by the Valve Academic Research Consortium-2. The PCI (n = 137) and Regular (n = 221) approaches were compared using the propensity score based method of inverse probability of treatment weighting. Results No differences were observed after comparison of TAVI performed with the PCI or regular approach regarding the composite safety endpoint (7.3% vs. 11.3%; odds ratio 0.63, 95% confidence interval 0.37 to 1.07; P = 0.086) or the composite efficacy endpoint (4.4% vs. 6.3%; odds ratio 0.78, 95% confidence interval 0.41 to 1.49; P = 0.45). Conclusions This study suggests that the efficacy and safety of TF-TAVI entirely managed by a PCI approach for selected patients are not different to those when TF-TAVI is performed with the attendance of a full anaesthesia care team. The PCI approach appears to be a safe and efficient clinical pathway, providing an appropriate and rational utilization of anaesthesiology resources, and could be used for the majority of TF-TAVI procedures.

Details

ISSN :
18752128
Volume :
114
Issue :
8-9
Database :
OpenAIRE
Journal :
Archives of cardiovascular diseases
Accession number :
edsair.doi.dedup.....522cfe39454ffa1bcc5d274c1fe37482